SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-021520
Filing Date
2021-12-02
Accepted
2021-12-02 19:46:18
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1648
  Complete submission text file 0001567619-21-021520.txt   3020
Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-41116 | Film No.: 211468328

Mailing Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016
Business Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016 2122874092
BioPlus Acquisition Corp. (Issuer) CIK: 0001856653 (see all company filings)

IRS No.: 981583272 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks